500420 Share Price Performance
₹0
-3578.45 (-100.00%)
Price ₹0
Fair Value₹5,386.76
Share Pricen/a
Narrative Update • Aug 14
Torrent Pharmaceuticals Limited Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 10 Fair Values set on narratives written by author
500420 Community Narratives
AN
Fair Value
·Fair Value ₹5.39k 6.7% undervalued intrinsic discount
Robust Indian And Brazilian Markets Will Unlock Potential
1users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
Robust Indian And Brazilian Markets Will Unlock Potential
Torrent Pharmaceuticals is leaning into fast-growing branded medicines in India and Brazil, with a steady stream of new launches aimed at long-term conditions like diabetes and obesity. The upside comes from building a deeper pipeline and expanding into higher-value therapies, but regulatory shocks, currency swings, and fierce generic competition could quickly squeeze profits.Read more
AN
₹5.39k
6.7% undervalued intrinsic discount
Fair Value
Revenue
19.15% p.a.
Profit Margin
17.39%
Future PE
77.14x
Price in 2029
₹7.65k
Trending Discussion
No trending discussion available.
Recently Updated Narratives
AN
500420: Dividend Support And Higher Assumptions Will Drive A Stronger Outlook
Fair Value: ₹5.39k 6.7% undervalued intrinsic discount
6 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Torrent Pharmaceuticals Limited Key Details
Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
- 57.35
- 75.98%
- 13.87%
- 85.4%
About 500420
- Founded
- 1959
- Employees
- 18258
- CEO
- WebsiteView website
Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, Malta, and internationally. The company offers products in various therapeutic areas, including anti-diabetic, anti-microbial, cardiovascular, CNS, urology, gynecology, oncology, gastro-intestinal, nephrology, neuro-psychiatric, dermatology, pulmonology, pediatric treatments, nutritional, pain management, anti-infective, and miscellaneous, as well as vitamins, minerals, and nutrients. It also provides contract manufacturing services. The company offers its products under Tedibar, Shelcal, Unienzyme, ProZuca, and Ahaglow brands. The company was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Private Limited.
Recent 500420 News & Updates
Narrative Update • Jul 31
